ASKA Pharmaceutical Holdings Co.,Ltd. (TYO:4886)

Market Cap	65.49B
Revenue (ttm)	64.14B
Net Income (ttm)	5.10B
Shares Out	28.36M
EPS (ttm)	179.94
PE Ratio	12.83
Forward PE	12.61
Dividend	55.00 (2.38%)
Ex-Dividend Date	Mar 28, 2025

Volume	25,900
Average Volume	49,850
Open	2,323.00
Previous Close	2,311.00
Day's Range	2,295.00 - 2,325.00
52-Week Range	1,825.00 - 2,720.00
Beta	0.46
RSI	49.36
Earnings Date	May 12, 2025

About TYO:4886

ASKA Pharmaceutical Holdings Co.,Ltd., through its subsidiaries, engages in the pharmaceutical, animal health, and hormone testing businesses in Japan. The company researches, develops, manufactures, and markets pharmaceutical products in the areas of endocrinology, obstetrics and gynecology, and urology; and researches, manufactures, sells, imports, and exports veterinary medicines, veterinary medical devices, feed and feed additives, reagents, agrochemicals, industrial chemicals, hygiene products, and food products and their raw materials. It...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1920
• Employees: 762
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 4886

Financial Performance

In 2024, TYO:4886's revenue was 64.14 billion, an increase of 2.06% compared to the previous year's 62.84 billion. Earnings were 5.10 billion, a decrease of -32.39%.